Mode
Text Size
Log in / Sign up

Lung Disease

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Lung Disease

8 trials tracked for Lung Disease: 2 in phase 3 or 4.

8Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 3 Other / NA 3
  1. Phase 4 PleuraSeal Post Market Study (Europe) Completed
  2. Phase 3 Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies Completed
  3. Phase 2 Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis Completed
  4. Phase 2 Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD) Completed
  5. Phase 2 AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD) Completed
  6. N/A Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP Facility Completed
Show 2 more trials
  1. N/A Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator Completed
  2. N/A DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations? Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.